After more than a year of development, Owlpharma is proud to announce the official launch of Owltech - a new consulting venture purpose - built to deliver specialized Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) services to pharmaceutical companies worldwide.

‍

Owltech was conceived as an individual company to complement the services already in place at Owlpharma, leveraging years of accumulated knowledge on this sector to answer directly to client requests and close some gaps in medicinal products lifecycle management.

‍

This new entity is designed to support organizations seeking to navigate complex projects, accelerate time to market and optimize operational processes — areas where regulatory expertise and specific know-how are critical success factors.

‍

The idea is to have services that truly go further and allow the clients to have a solution without having to manage multiple partners, increasing the trust and reliability in the process developed.

‍

Owltech is the solution for you!

‍